Does ALEMTUZUMAB Cause Hypoaesthesia? 523 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 523 reports of Hypoaesthesia have been filed in association with ALEMTUZUMAB (Campath). This represents 3.7% of all adverse event reports for ALEMTUZUMAB.
523
Reports of Hypoaesthesia with ALEMTUZUMAB
3.7%
of all ALEMTUZUMAB reports
10
Deaths
230
Hospitalizations
How Dangerous Is Hypoaesthesia From ALEMTUZUMAB?
Of the 523 reports, 10 (1.9%) resulted in death, 230 (44.0%) required hospitalization, and 18 (3.4%) were considered life-threatening.
Is Hypoaesthesia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 523 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Hypoaesthesia?
ADALIMUMAB (7,423)
ETANERCEPT (4,497)
METHOTREXATE (4,175)
RITUXIMAB (3,605)
TOFACITINIB (3,324)
PREDNISONE (3,239)
TOCILIZUMAB (3,238)
FINGOLIMOD (3,180)
LENALIDOMIDE (3,127)
SECUKINUMAB (3,079)
Which ALEMTUZUMAB Alternatives Have Lower Hypoaesthesia Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET